Dr. Deborah Marshall, PhD

Deborah Marshall

Professor

Cumming School of Medicine, Department of Community Health Sciences

Scientific Director, Research and Partnership Evaluation and Impact

Alberta Children's Hospital Research Institute

Child Health & Wellness Researcher

Alberta Children's Hospital Research Institute

Full Member

McCaig Institute for Bone and Joint Health

Media contacts

Kelly Johnston
Senior Communications Specialist

Office: +1.403.220.5012
Email: kelly.johnston2@ucalgary.ca
Twitter: @UCalgarymed

Background

Educational Background

B.S. Biochemistry, University of Toronto, 1988

Doctor of Philosophy Health Services Research, University of North Carolina, 1998

Master Health Serv Administrtn Health Services Research, University of Alberta, 1990

Biography

I lead the health economics, socioeconomic benefits patient preferences and patient engagement activities for several national and international research programmes in precision health and patient-oriented research to develop health economic tools and approaches to evaluate precision health:

  1. UCAN CAN-DU (Understanding Childhood Arthritis Network Canada-Netherlands personalized medicine network in childhood arthritis and rheumatic disease, funded through CIHR/Genome Canada Large Scale Applied Research Program) – focused on genomic science linked to molecular mechanism, machine learning, and economic modelling to transform clinical practice and health policy.
  2. UCAN CURE (Precision Decisions for Childhood Arthritis, CIHR/Genome Canada Large Scale Applied Research Program Genomics and Precision Health grant) – we combine genomic techniques, machine learning methods and simulation modelling to predict response to treatment and its associate health outcomes and economic impact.
  3. SOLVE (Care4Rare Canada: Harnessing multi-omics to deliver innovative diagnostic care for rare genetic diseases in Canada) CIHR/Genome Canada Large Scale Applied Research Program.
  4. TIGeR (Translational Implementation of Genomics for Rare diseases), partnership with Medical Genetics and Alberta Provincial Laboratory for the clinical application of genome wide sequencing funded by Genome Alberta, Genomic Applications Partnership Program (GAPP).
  5. IMAGINE Strategy for Patient Oriented Research (SPOR) Chronic Disease Network (Inflammation, Microbiome, and Alimentation: Gastro-Intestinal and Neuropsychiatric Effects, CIHR SPOR) on inflammatory bowel disease and the microbiome.

My research networks in PH includes ongoing collaborations since 2010 with Dr. Kathryn Phillips on US National Institute of Health grants on personalized medicine and health policy applications. This research catalysed the establishment of the Centre for Translational and Policy Research on Personalized Medicine (TRANSPERS). TRANSPERS focuses on providing objective evidence on adoption, payer coverage policies, payer and clinician decision-making, and economic value. In 2018, we created the Global Economics and Evaluation of Clinical Genomics Sequencing Working Group (GEECS) – a group of health economists and policy researchers from major institutions across the globe (Oxford University, Harvard University, University of California San Francisco, University of Calgary, and University of British Columbia) doing research on economic methods for incorporating genomics into clinical care.

Research

Areas of Research

Health economics
Patient preferences
Health services research
Precision health
Patient-oriented research
Assessment of impact
Activities

Deborah is a health services researcher and health economist leading a program of applied research to assess the value of health care interventions using patient preferences, patient engagement, cost-effectiveness analysis and simulation modelling methods. She has experience in technology assessment agencies, academia and pharmaceutical and diagnostics industry research settings in Canada, the United States, and Europe. She leads the health economics, patient preferences and patient engagement activities for 4 large national and international research programmes in precision medicine: 1) UCAN CAN DU (Understanding Childhood Arthritis Network Canada-Netherlands personalized medicine network in childhood arthritis and rheumatic disease, CIHR/Genome Canada); 2) UCAN CURE (Precision Decisions for Childhood Arthritis, CIHR/Genome Canada); 3) SOLVE (Care4Rare Canada: Harnessing multi-omics to deliver innovative diagnostic care for rare genetic diseases); and, 4) IMAGINE SPOR Chronic Disease Network (Inflammation, Microbiome, and Alimentation: Gastro-Intestinal and Neuropsychiatric Effects, CIHR SPOR).

A key aspect of Deborah's research is in childhood arthritis to lead the health economic platform of our Understanding Childhood Arthritis Network precision health team grants.

Participation in university strategic initiatives

Courses

Course number Course title Semester
MDCH 662 LEC 01 01 Economic Evaluation 2020
MDCH 70061 LEC 02 02 Community Hlth Directed Study 2020

Awards

  • Canadian Academy of Health Sciences (CAHS) Fellowship Award, University of Calgary. 2020
  • Killam Annual Professorship Award, University of Calgary. 2019
  • Dr. Jill M, Sanders Award of Excellent in Health Technology Assessment, Canadian Agency for Drugs and Technologies in Health (CADTH). 2019
  • O'Brien Institute Research Excellence Award, University of Calgary. 2017
  • Distinguished Achievement Cochrane Award for Research, Faculty of Medicine. 2013
  • Early Career Excellence in Graduate Education, Graduate Science Education Award, University of Calgary. 2012
  • Graduate Students' Association Supervisory Excellence Award, University of Calgary. 2012
  • President Board of Directors, International Society for Pharmacoeconomics and Outcomes Research (ISPOR). 2012
  • CIHR Celebration of Excellence in Health Research Knowledge Translation Award, Canadian Medical Association Journal (CMAJ). 2011
  • Canada Research Chair, Health Systems and Services Research Salary Support Award, Canada Research Chair. 2008
  • Arthur J.E. Child Chair in Rheumatology Research, 2021